JP2018536163A5 - - Google Patents

Download PDF

Info

Publication number
JP2018536163A5
JP2018536163A5 JP2018526566A JP2018526566A JP2018536163A5 JP 2018536163 A5 JP2018536163 A5 JP 2018536163A5 JP 2018526566 A JP2018526566 A JP 2018526566A JP 2018526566 A JP2018526566 A JP 2018526566A JP 2018536163 A5 JP2018536163 A5 JP 2018536163A5
Authority
JP
Japan
Prior art keywords
dye
primary antibody
enzyme
tissue sample
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018526566A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018536163A (ja
JP6832930B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/078237 external-priority patent/WO2017085307A1/en
Publication of JP2018536163A publication Critical patent/JP2018536163A/ja
Publication of JP2018536163A5 publication Critical patent/JP2018536163A5/ja
Application granted granted Critical
Publication of JP6832930B2 publication Critical patent/JP6832930B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018526566A 2015-11-22 2016-11-21 Pd−l1陽性腫瘍組織における免疫細胞を同定する方法 Active JP6832930B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562258493P 2015-11-22 2015-11-22
US62/258,493 2015-11-22
PCT/EP2016/078237 WO2017085307A1 (en) 2015-11-22 2016-11-21 Methods of identifying immune cells in pd-l1 positive tumor tissue

Publications (3)

Publication Number Publication Date
JP2018536163A JP2018536163A (ja) 2018-12-06
JP2018536163A5 true JP2018536163A5 (https=) 2019-11-07
JP6832930B2 JP6832930B2 (ja) 2021-02-24

Family

ID=57391956

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018526566A Active JP6832930B2 (ja) 2015-11-22 2016-11-21 Pd−l1陽性腫瘍組織における免疫細胞を同定する方法

Country Status (7)

Country Link
US (1) US11899016B2 (https=)
EP (1) EP3377530B1 (https=)
JP (1) JP6832930B2 (https=)
AU (1) AU2016357478B2 (https=)
CA (1) CA3005804C (https=)
ES (1) ES2886600T3 (https=)
WO (1) WO2017085307A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102389677B1 (ko) 2013-03-15 2022-04-21 제넨테크, 인크. Pd-1 및 pd-l1 관련 상태를 치료하기 위한 바이오마커 및 방법
ES2916923T3 (es) * 2014-07-11 2022-07-06 Ventana Med Syst Inc Anticuerpos anti-PD-L1 y usos diagnósticos de los mismos
EP3596114A2 (en) 2017-03-16 2020-01-22 Alpine Immune Sciences, Inc. Cd80 variant immunomodulatory proteins and uses thereof
US12065476B2 (en) 2018-06-15 2024-08-20 Alpine Immune Sciences, Inc. PD-1 variant immunomodulatory proteins and uses thereof
AU2019345151B2 (en) 2018-09-19 2025-04-17 Alpine Immune Sciences, Inc. Methods and uses of variant CD80 fusion proteins and related constructs
JP7259019B2 (ja) 2018-09-20 2023-04-17 ヴェンタナ メディカル システムズ, インク. フローサイトメトリデータを分析するためのサイズに基づくゲーティング
CN112789684B (zh) 2018-10-01 2025-05-09 文塔纳医疗系统公司 用于预测对pd-1轴导向疗法的应答的方法和系统
CN113383089A (zh) 2018-11-29 2021-09-10 文塔纳医疗系统公司 经由代表性DNA测序进行个性化ctDNA疾病监测
WO2021224293A1 (en) * 2020-05-07 2021-11-11 Ventana Medical Systems, Inc. Histochemical systems and methods for evaluating egfr and egfr ligand expression in tumor samples
CN111830256A (zh) * 2020-07-01 2020-10-27 北京基谱生物科技有限公司 一种石蜡切片免疫荧光多重染色试剂盒及使用方法
JPWO2022059601A1 (https=) * 2020-09-16 2022-03-24
CN118786346A (zh) * 2022-03-07 2024-10-15 阿斯利康(瑞典)有限公司 用于预测患者对免疫疗法的应答的方法
WO2023172883A1 (en) 2022-03-07 2023-09-14 Alpine Immune Sciences, Inc. Immunomodulatory proteins of variant cd80 polypeptides, cell therapies thereof and related methods and uses
JP2025526652A (ja) * 2022-08-08 2025-08-15 ヴェンタナ メディカル システムズ, インク. デジタル化された病理スライドの定量化のためのシステムおよび方法
CN121368715A (zh) 2023-04-13 2026-01-20 文塔纳医疗系统公司 用于固定的实体瘤的增殖测定
WO2025193604A1 (en) 2024-03-11 2025-09-18 Ventana Medical Systems, Inc. Non-enzymatic dissociation of ffpe tissue and generation of single cells with intact cell surface markers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01004287A (es) * 1998-10-26 2002-06-04 Ventana Med Syst Inc Deteccion del virus del papiloma humano en frotis de papanicolau (pap).
US6544798B1 (en) 1999-02-26 2003-04-08 Ventana Medical Systems, Inc. Removal of embedding media from biological samples and cell conditioning on automated staining instruments
US6195451B1 (en) * 1999-05-13 2001-02-27 Advanced Pathology Ststems, Inc. Transformation of digital images
US8071322B2 (en) * 2002-11-12 2011-12-06 Epitomics, Inc. Method for identifying differentially expressed proteins
WO2012003476A2 (en) * 2010-07-02 2012-01-05 Ventana Medical Systems, Inc. Hapten conjugates for target detection
EP2831587B1 (en) * 2012-03-27 2018-05-16 Ventana Medical Systems, Inc. Signaling conjugates and methods of use
CN113967253A (zh) * 2012-05-15 2022-01-25 百时美施贵宝公司 通过破坏pd-1/pd-l1信号传输的免疫治疗
WO2014194293A1 (en) * 2013-05-30 2014-12-04 Amplimmune, Inc. Improved methods for the selection of patients for pd-1 or b7-h4 targeted therapies, and combination therapies thereof
AU2014293154A1 (en) * 2013-07-24 2016-02-18 Dana-Farber Cancer Institute, Inc. Anti-galectin-1 monoclonal antibodies and fragments thereof
EP3079772B1 (en) * 2013-12-10 2020-02-05 Merck Sharp & Dohme Corp. Immunohistochemical proximity assay for pd-1 positive cells and pd-ligand positive cells in tumor tissue
WO2015124703A1 (en) * 2014-02-24 2015-08-27 Ventana Medical Systems, Inc. Quinone methide analog signal amplification

Similar Documents

Publication Publication Date Title
JP2018536163A5 (https=)
Qu et al. Innovative FO-SPR label-free strategy for detecting anti-RBD antibodies in COVID-19 patient serum and whole blood
Brummelman et al. Development, application and computational analysis of high-dimensional fluorescent antibody panels for single-cell flow cytometry
Anderson et al. Fully automated RNAscope in situ hybridization assays for formalin‐fixed paraffin‐embedded cells and tissues
Arola et al. Specific noncompetitive immunoassay for HT-2 mycotoxin detection
Wang et al. Biosensors for the detection of Bacillus anthracis
JP2012510618A5 (https=)
HRP20160461T1 (hr) Solubilna humana st-2 antitijela i eseji
WO2012056407A8 (en) Antibodies which bind soluble t-cell receptor ligands
JP2011524537A5 (https=)
US20170176423A1 (en) Magnetic programmable bead enzyme-linked immunosorbent assay
WO2013132347A3 (en) Improved elisa immunoassay for calprotectin
Wu et al. Magnetic-based enrichment of rare cells from high concentrated blood samples
Lin et al. Rapid detection of hepatitis B virus in blood samples using a combination of polymerase spiral reaction with nanoparticles lateral-flow biosensor
Andersson et al. Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells
Skottrup et al. Rapid determination of Phytophthora infestans sporangia using a surface plasmon resonance immunosensor
CN109416356A (zh) 使用ip-质谱法的抗体验证
JP2017026631A5 (https=)
CN107937490A (zh) 一种非对称pcr的试纸条检测植物病原菌的方法及试剂盒
Lyu et al. Generation and screening of antigen-specific nanobodies from mammalian cells expressing the BCR repertoire library using droplet-based microfluidics
Gulinaizhaer et al. Detection of monkeypox virus using helicase dependent amplification and recombinase polymerase amplification combined with lateral flow test
Wei et al. Ultrasensitive “hunter of target”: rabbit monoclonal antibody-based competitive lateral flow immunoassay for saxitoxin
BRPI1013201A2 (pt) meios e métodos para reconhecer o desenvolvimento de doenças cardiovascular em um indivíduo
Wang et al. A magnetic-optical triple-mode lateral flow immunoassay for sensitive and rapid detection of respiratory adenovirus
Al-Amin et al. Sensitive protein detection using site-specifically oligonucleotide-conjugated nanobodies